口服RNAi输送以准Ftz-F1β/JAK-STAT信号轴,以提高的免疫力,防止病原体感染
Hongliang Zuo1, Youxi Wang2, Xiya Yang2
1State Key Laboratory of Biocontrol, School of Life Sciences/ Southern Marine Science and Engineering Guangdong Laboratory (Zhuhai)/ China-ASEAN Belt and Road Joint Laboratory on Mariculture Technology, Sun Yat-sen University, Guangzhou, PR China; Institute of Aquatic Economic Animals and Guangdong Province Key Laboratory for Aquatic Economic Animals, Sun Yat-sen University, Guangzhou, PR China.
International journal of biological macromolecules
|August 14, 2025
概括
研究人员发现了一种新的方法来提高的免疫力. 通过向FtzF1β蛋白,他们激活了JAK-STAT通路,提高了太平洋白的抗病能力和生存率.
科学领域:
- 无脊椎动物免疫学 无脊椎动物免疫学
- 免疫反应的分子机制
- 水产养殖疾病管理
背景情况:
- 该JAK-STAT信号通路对于对病原体的免疫反应至关重要.
- 细胞因子信号传递2抑制剂 (SOCS2) 负面调节这种途径.
- 太平洋白 (Penaeus vannamei) 水产养殖在经济上具有重要意义.
研究的目的:
- 为了识别中JAK-STAT信号的新型调节者.
- 调查fushi tarazu F1β (FtzF1β) 在免疫调节中的作用.
- 制定提高抗病能力的策略.
主要方法:
- 分析了FtzF1β的构成表达和核定位.
- 通过促进体结合试验检查了FtzF1β在调节SOCS2转录中的作用.
- 使用RNA干扰 (RNAi) 来抑制FtzF1β的表达.
- 开发并测试了针对FtzF1β的口服RNAi输送系统.
主要成果:
- FtzF1β作为转录因子,对SOCS2进行上调并抑制JAK-STAT信号传递.
- 在暴露于病原体时,FtzF1β的表达会增加.
- FtzF1β敲击增强了免疫基因表达和细胞化.
- 口服RNAi输送FtzF1β dsRNA激活了JAK-STAT信号,改善了的生存率.
结论:
- 在中发现了一种新的FtzF1β介导的JAK-STAT抑制轴.
- FtzF1β是免疫反应的关键抑制剂.
- 通过口服RNAi向FtzF1β为水产养殖提供了一个有希望的疾病控制策略.
相关概念视频
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
RNA Interference
26.4K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.4K


